Determinants of influenza and pneumococcal vaccination in elderly people:: a systematic review

被引：80

作者：

Kohlhammer, Y. ^{[1
]}

Schnoor, M. ^{[1
]}

Schwartz, M. ^{[1
]}

Raspe, H. ^{[1
]}

Schaefer, T. ^{[1
]}

机构：

[1] Med Univ Schleswig Holstein, Inst Social Sci, D-23552 Lubeck, Germany

来源：

PUBLIC HEALTH | 2007年 / 121卷 / 10期

关键词：

influenza vaccination; pneumococcal vaccination; prevention; review; POLYSACCHARIDE VACCINE; SELF-REPORT; OLDER; IMMUNIZATION; ADULTS; PREVALENCE; AGE; BACTEREMIA; TELEPHONE; KNOWLEDGE;

D O I：

10.1016/j.puhe.2007.02.011

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objectives: Despite strong national and international recommendations on immunization practices, rates for influenza (IV) and pneumococcal vaccinations (PV) are low. We aimed to review international immunization rates and to analyze attitudes and beliefs regarding IV and PV. Study design: Systematic review. Method: The MEDLINE database search comprised articles from 1966 to October 2005. Fourteen surveys evaluating a total number of 49292 participants in nine different countries were included into the analysis. Results: Vaccination rates among risk groups do vary significantly between different countries, reaching highest rates in the USA (IV, 82%; PV, 71%) and lowest in former West-Germany for IV (37%) and in Israel for PV (20%). Recommendations by doctors play a central rote in promoting IV and PV. The main reason for not being vaccinated was lack of information. Conclusion: Specific strategies targeted at groups are needed to increase the knowledge of IV and PV, and thereby decrease incidences of acute lung diseases. (c) 2007 The Royal Institute of Public Health. Published by Elsevier Ltd. All. rights reserved.

引用

页码：742 / 751

页数：10

共 46 条

[1] Influenza vaccination in 29 countries - An update to 1997 [J].

Ambrosch, F ;

Fedson, DS .

PHARMACOECONOMICS, 1999, 16 (Suppl 1) :47-54

[2]

[Anonymous], 2000, MMWR Recomm Rep, V49, P1

[3]

Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1

[4] Pneumococcal drug resistance: The new "special enemy of old age" [J].

Butler, JC ;

Cetron, MS .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) :730-735

[5] The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons [J].

Chi, RC ;

Neuzil, KM .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 327 (03) :113-117

[6] Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection [J].

Christenson, B ;

Lundbergh, P .

EPIDEMIOLOGY AND INFECTION, 2002, 129 (03) :515-524

[7]

D'Argenio P, 2001, Euro Surveill, V6, P26

[8] A national survey of physician practices regarding influenza vaccine [J].

Davis, MM ;

McMahon, SR ;

Santoli, JM ;

Schwartz, B ;

Clark, SJ .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (09) :670-676

[9]

Drinkovic D, 2001, NEW ZEAL MED J, V114, P326

[10] Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul Metropolitan area [J].

Ehresmann, KR ;

Ramesh, A ;

Como-Sabetti, K ;

Peterson, DC ;

Whitney, CG ;

Moore, KA .

PREVENTIVE MEDICINE, 2001, 32 (05) :409-415

← 1 2 3 4 5 →